FGF19 and muscle architecture in older patients
Background: Sarcopenia has a significant medical and economic impact. Serum fibroblast growth factor 19 (FGF19) has recently been described as promoting muscle mass and strength, and could be an interesting marker for early diagnosis of sarcopenia and prevention of its consequences. Ultrasound is a...
Main Authors: | Emilie Bres, Julia Bouvier, Aymeric Courtay, Léo Delaire, Joannes Humblot, Charlotte Cuerq, Stéphanie Tripoz-Dit-Masson, Mathieu Fauvernier, Thomas Gilbert, Marc Bonnefoy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | Experimental Gerontology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0531556523000414 |
Similar Items
-
Integrating a Prevention Care Path into the Daily Life of Older Adults with Mobility Disability Risk: Introducing a Predictive Response Model to Exercise
by: Delaire L, et al.
Published: (2021-09-01) -
Fgf22 regulated by Fgf3/Fgf8 signaling is required for zebrafish midbrain development
by: Ayumi Miyake, et al.
Published: (2013-04-01) -
DNA methylation of skeletal muscle function‐related secretary factors identifies FGF2 as a potential biomarker for sarcopenia
by: Jia‐Wen Li, et al.
Published: (2024-06-01) -
FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
by: Emma Henriksson, et al.
Published: (2020-12-01) -
Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance
by: Oshadi Edirisinghe, et al.
Published: (2024-12-01)